Ribociclib CDK (cyclin-dependent kinase) inhibitor
Description Results

LEE011 - ribociclib      

  • Group by...

pdf
pathology Benefit (demonstrated or suggested) and harm      
advanced breast cancer (metastatic)

superior to letrozole alone in terms of progression free survival in MONALEESA-2, 2016 (first line patients)

meta-analysis



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons